Ultra Market Research | Global Coronary Stents Market
Global Coronary Stents Market
Report ID : 881
Category : Medical-Devices,Global
No Of Pages : 121
Published on: December 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Coronary Stents Market Introduction Global Coronary Stents Market refers to the medical devices market used in the treatment of coronary artery disease or the implantation of stents within the arteries to avoid them from collapsing or shrinking in size. Coronary stents are small mesh tubes placed into an artery during angioplasty so that they do not block off again. The stents are an important part of the treatment process to remove the blockage of plaque in the coronary artery which would prevent heart attacks and stroke. The main use of coronary stents is through interventional cardiology procedures. Presently, the trend for global coronary stents market is changing with drug-eluting stents, which deliver medicine for the prevention of the arteries' re-narrowing. The increased occurrence of cardiovascular diseases increases the demand in the market. The market size is likely to grow exponentially with the increase in the geriatric population and technological advancement in the design of stents. The present market scenario reflects a strong demand that is driven by the growth in the incidence of heart diseases and increased access to healthcare.
Segmentation Type of Coronary Stents • Drug-Eluting Stents o Polymer-Based Drug-Eluting Stents o Non-Polymer-Based Drug-Eluting Stents o Others • Bare-Metal Stents o Stainless Steel Bare-Metal Stents o Cobalt-Chromium Bare-Metal Stents o Others • Bioresorbable Stents o Poly-L-lactic Acid (PLLA) Stents o Magnesium Stents o Others
End-User • Hospitals o Public Hospitals o Private Hospitals o Cardiac Centers • Ambulatory Surgical Centers (ASCs) o Independent Surgical Centers o Multi-specialty Centers o Others
Material Used • Stainless Steel • Cobalt-Chromium Alloy • Nickel-Titanium Alloys • Others
Geography • North America o United States o Canada • Europe o Germany o United Kingdom o France o Italy o Others • Asia-Pacific o China o Japan o India o South Korea o Others • Rest of the World
List of Market Players • Medtronic (Ireland) • Abbott Laboratories (USA) • Boston Scientific (USA) • Johnson & Johnson (USA) • Terumo Corporation (Japan) • Biotronik (Germany) • Cordis (USA) • B. Braun Melsungen AG (Germany) • Cook Medical (USA) • Straub Medical (Switzerland) • Merit Medical Systems (USA) • Elixir Medical (USA) • OrbusNeich Medical (Hong Kong) • Asahi Intecc (Japan) • Medico's Hirata (Japan)
Drivers Global coronary stents market can be primarily attributed to several aspects: the prevalence of the rising CVDs cases, particularly coronary artery diseases, which are one of the primary causes of death cases across the world. The aging population is relatively prone to such conditions, while increased demand for coronary stents is a result of an upsurge in related disease cases. Furthermore, new technologies such as drug-eluting and bioresorbable stents made the procedures more effective and thus decreased complications. Another key driver of this trend is the rapidly increasing use of minimally invasive procedures in interventional cardiology. In addition, medical treatments such as coronary stenting are becoming more accessible through improving healthcare systems in the emerging economies. The rising awareness about the benefits of stents in heart diseases is driving demand further.
Restraints Despite the increasing demand, the global coronary stents market has several challenges. High cost is one of the major restraints in this market, especially for the advanced coronary stents that include drug-eluting and bioresorbable stents, which may be unaffordable for patients in lower-income regions. Complications associated with the implantation of stents, such as restenosis or re-narrowing of the artery and thrombosis or formation of blood clots, continue to be a challenge. While not few, some coronary interventions remain complex and risky: those requiring special skills do limit the spread of this kind of stent treatment. Tighter regulatory clearances will require a significant amount to be spent on research and development into future generations of stents-thereby limiting market expansion. Finally, the use of increasingly effective lifestyle modifications and medical treatment therapies also challenges demand from more demand.
Opportunity Growth opportunities include an increase in cardiovascular health awareness and developing health care infrastructure in emerging markets. There is an increased demand for minimally invasive surgery because patients are seeking quicker recovery times and fewer complications. Technological advances, including drug-eluting and bioresorbable stents, allow for meeting patient-specific needs and improving clinical outcomes. Personalized medicine focus and stent design advancements, including biocompatibility and drug delivery mechanisms, expand market potential further. Increased research and development activities to develop cost-effective stents will provide opportunities for expansion in price-sensitive regions. Collaborations between medical device companies and healthcare providers can facilitate the introduction of advanced stents in emerging markets.
Trend One of the most important trends in the global coronary stents market is the shift toward bioresorbable and drug-eluting stents, designed to improve long-term patient outcomes. Bioresorbable stents, in particular, are getting more attention because they dissolve after a certain period, thus preventing permanent foreign body presence in the artery. The trend is further supported by new stent materials, like magnesium and PLLA, that enhance the efficacy and decrease adverse events. Additionally, advanced imaging techniques, such as IVUS and OCT, are increasingly used in conjunction with stent placement. These technologies allow doctors to position the stent much more accurately and effectively, leading to better clinical results. This, as a result, has shaped the stent market to be patient-centric with state-of-the-art technology.
Key Target Audience • Hospitals and Cardiovascular Clinics • Interventional Cardiologists • Healthcare Providers • Medical Device Manufacturers • Research Institutes and Academia • Regulatory Bodies and Health Authorities • Investment and Financial Institutions • Healthcare Distributors and Suppliers • Cardiac Device Design and Development Teams • Government Health Agencies
Frequently Asked Questions (FAQ's)
The global coronary stents market size is projected to experience substantial growth due to increasing cardiovascular diseases and advancements in stent technology.
The market offers drug-eluting stents, bare-metal stents, bioresorbable stents, and others, each with unique applications.
The growing elderly population is a significant driver for the coronary stents market due to the higher risk of cardiovascular diseases in older individuals.
Bioresorbable stents are gaining popularity due to their ability to dissolve after treatment, which is expected to increase their adoption in the future.
Challenges include high product costs, risks associated with stent implantation, and competition from alternative treatments like drug therapies.
1. Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
2. Market Dashboard
3. Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Material Type
Metallic Stents Cobalt-Chromium Platinum-Chromium Stainless Steel Others Polymeric Stents Fully Degradable Stents Partially Degradable Stents 3.2.2 By Stent Type Drug-Eluting Stents (DES) First-Generation DES Second-Generation DES Bare Metal Stents (BMS) Coated BMS Uncoated BMS Bioresorbable Vascular Scaffolds (BVS) Polymer-Based Metallic-Based 3.2.3 By End-User Hospitals Government Hospitals Private Hospitals Ambulatory Surgical Centers (ASCs) Cardiac Centers Specialty Cardiac Clinics Diagnostic Centers 3.2.4 By Distribution Channel Hospital Pharmacies Inpatient Dispensing Specialty Drug Distribution Retail Pharmacies Chain Pharmacies Standalone Pharmacies Online Pharmacies 3.2.5 By Geography 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges
4. Global Coronary Stents Market by Material Type 4.1 Introduction 4.2 Market Size and Growth Rate by Material Type (2024–2030) 4.2.1 Metallic Stents 4.2.2 Polymeric Stents
5. Global Coronary Stents Market by Stent Type 5.1 Introduction 5.2 Market Size and Growth Rate by Stent Type (2024–2030) 5.2.1 Drug-Eluting Stents (DES) 5.2.2 Bare Metal Stents (BMS) 5.2.3 Bioresorbable Vascular Scaffolds (BVS)
6. Global Coronary Stents Market by End-User 6.1 Introduction 6.2 Market Size and Growth Rate by End-User (2024–2030) 6.2.1 Hospitals 6.2.2 Ambulatory Surgical Centers (ASCs) 6.2.3 Cardiac Centers
7. Global Coronary Stents Market by Distribution Channel 7.1 Introduction 7.2 Market Size and Growth Rate by Distribution Channel (2024–2030) 7.2.1 Hospital Pharmacies 7.2.2 Retail Pharmacies 7.2.3 Online Pharmacies
8. Global Coronary Stents Market by Geography 8.1 Introduction 8.2 Market Size and Growth Rate by Region (2024–2030) 8.2.1 North America
United States Canada 8.2.2 Europe Germany France United Kingdom Rest of Europe 8.2.3 Asia Pacific China Japan India Southeast Asia Rest of Asia Pacific 8.2.4 Latin America Brazil Rest of Latin America 8.2.5 Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.2 Medtronic plc (Ireland) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.3 Boston Scientific Corporation (United States) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.4 B. Braun Melsungen AG (Germany) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.5 Terumo Corporation (Japan) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.6 MicroPort Scientific Corporation (China) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.7 Biosensors International Group, Ltd. (Singapore) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.8 Cook Medical (United States) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.9 Biotronik SE & Co. KG (Germany) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.10 SMT (India) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.11 OrbusNeich (Hong Kong) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.12 Meril Life Sciences Pvt. Ltd. (India) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.13 Lepu Medical Technology (China) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.14 Sino Medical Sciences Technology (China) Business Overview Product Portfolio Strategic Developments Financial Overview 9.1.15 C. R. Bard, Inc. (United States) Business Overview Product Portfolio Strategic Developments Financial Overview
List of Tables and Figures Table 1: Market Size by Material Type (2024–2030) Table 2: Market Size by Stent Type (2024–2030) Table 3: Market Size by End-User (2024–2030) Table 4: Market Size by Distribution Channel (2024–2030) Table 5: Market Size by Region (2024–2030) Figure 1: Global Coronary Stents Market Dynamics Figure 2: Market Share by Material Type (2024) Figure 3: Geographic Breakdown of Market Revenue (2024)
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global Coronary Stents Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue North Americaly. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Coronary Stents Market for the past year and forecasts for the next six years. Global Coronary Stents Market . Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global Coronary Stents Market categories. Market size and forecasts for each major application is provided in the context of North America market. The numbers provided in this report are derived on the basis of demand for Global Coronary Stents Market from different application industries in different regions.
Segmentation Type of Coronary Stents • Drug-Eluting Stents o Polymer-Based Drug-Eluting Stents o Non-Polymer-Based Drug-Eluting Stents o Others • Bare-Metal Stents o Stainless Steel Bare-Metal Stents o Cobalt-Chromium Bare-Metal Stents o Others • Bioresorbable Stents o Poly-L-lactic Acid (PLLA) Stents o Magnesium Stents o Others
End-User • Hospitals o Public Hospitals o Private Hospitals o Cardiac Centers • Ambulatory Surgical Centers (ASCs) o Independent Surgical Centers o Multi-specialty Centers o Others
Material Used • Stainless Steel • Cobalt-Chromium Alloy • Nickel-Titanium Alloys • Others
Geography • North America o United States o Canada • Europe o Germany o United Kingdom o France o Italy o Others • Asia-Pacific o China o Japan o India o South Korea o Others • Rest of the World
